Year: 2025
Type: article
Abstract: Clinical science in the field of infectious diseases (ID) moved at a rapid pace in 2024. Among the highlights were multiple trials of new antibiotics and new approaches to prevent infections. Concerning trends, with outbreaks of dengue, measles, mpox, and highly pathogenic avian influenza A in 2024, demonstrate the importance of ID and the continued need for further advances through clinical science. This review highlights some of the most important trials and clinical trends in ID over the past year.
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciaf037
Authors: Jeffrey A Freiberg, Patty W Wright
Institutions: Vanderbilt University, Vanderbilt University Medical Center
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,763
OpenAlex ID: W4407064167